169882-29-5

Basic information

• Product Name: 3-[2-bromo-4-(1-methylethyl)phenyl]-7-chloro-5-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine
• Synonyms: 3-[2-bromo-4-(1-methylethyl)phenyl]-7-chloro-5-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine
• CAS NO: 169882-29-5
• Molecular Weight: 366.648
• Mol File: 169882-29-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-[2-bromo-4-(1-methylethyl)phenyl]-7-chloro-5-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[2-bromo-4-(1-methylethyl)phenyl]-7-chloro-5-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine(169882-29-5)
• EPA Substance Registry System: 3-[2-bromo-4-(1-methylethyl)phenyl]-7-chloro-5-methyl-3H-1,2,3-triazolo[4,5-d]pyrimidine(169882-29-5)

Safety Data

• Hazardous Substances Data: 169882-29-5(Hazardous Substances Data)

Upstream product

• 169883-27-6 4-N-<2-bromo-4-(1-methylethyl)phenyl>-6-chloro-2-methylpyrimidine-4,5-diamine 
• 53925-27-2 2-methyl-4,6-dihydroxy-5-nitropyrimidine 
• 1194-22-5 2-methyl-4,6-dihydroxypyrimidine 
• 13162-43-1 4,6-dichloro-2-methyl-5-nitropyrimidine 
• 51605-97-1 2-bromo-4-isopropylaniline 
• 39906-04-2 5-amino-4,6-dichloro-2-methylpyrimidine 

Relevant articles and documents

1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer'disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, or fertility problems. The novel compounds provided by this invention are those of formula: wherein R 1, R 3, R 4, R 5, Z, Y, V, X, X', J, K, L, and M are as defined herein.

Arylamino fused pyrimidines

Corticotropin releasing factor (CRF) antagonists of formula I or formula II: and their use in treating anxiety, depression, and other psychiatric and neurological disorders.